A detailed history of Federated Hermes, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 670,354 shares of ZTS stock, worth $110 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
670,354
Previous 635,204 5.53%
Holding current value
$110 Million
Previous $110 Million 18.94%
% of portfolio
0.3%
Previous 0.27%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$172.58 - $196.48 $6.07 Million - $6.91 Million
35,150 Added 5.53%
670,354 $131 Million
Q2 2024

Aug 08, 2024

SELL
$145.54 - $178.83 $20,230 - $24,857
-139 Reduced 0.02%
635,204 $110 Million
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $7.88 Million - $9.51 Million
47,558 Added 8.09%
635,343 $108 Million
Q4 2023

Jan 31, 2024

SELL
$151.44 - $200.09 $6.53 Million - $8.62 Million
-43,105 Reduced 6.83%
587,785 $116 Million
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $4.15 Million - $4.78 Million
-24,806 Reduced 3.78%
630,890 $110 Million
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $2.82 Million - $3.26 Million
17,504 Added 2.74%
655,696 $113 Million
Q1 2023

May 08, 2023

SELL
$145.48 - $175.02 $5.52 Million - $6.65 Million
-37,976 Reduced 5.62%
638,192 $106 Million
Q4 2022

Feb 13, 2023

SELL
$131.14 - $157.47 $7.5 Million - $9.01 Million
-57,217 Reduced 7.8%
676,168 $99.1 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $11.5 Million - $14.2 Million
77,723 Added 11.85%
733,385 $109 Million
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $39.5 Million - $50.7 Million
-253,488 Reduced 27.88%
655,662 $113 Million
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $37.2 Million - $48 Million
-205,288 Reduced 18.42%
909,150 $171 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $1.74 Million - $2.22 Million
8,977 Added 0.81%
1,114,438 $272 Million
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $11.2 Million - $12.4 Million
59,127 Added 5.65%
1,105,461 $215 Million
Q2 2021

Aug 16, 2021

BUY
$155.9 - $187.99 $2.62 Million - $3.16 Million
16,833 Added 1.64%
1,046,334 $195 Million
Q1 2021

May 13, 2021

SELL
$144.0 - $169.39 $5.67 Million - $6.67 Million
-39,386 Reduced 3.68%
1,029,501 $162 Million
Q4 2020

Feb 12, 2021

SELL
$157.07 - $174.35 $3.69 Million - $4.1 Million
-23,490 Reduced 2.15%
1,068,887 $177 Million
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $7.62 Million - $9.19 Million
55,589 Added 5.36%
1,092,377 $181 Million
Q2 2020

Aug 13, 2020

SELL
$111.92 - $142.53 $3.35 Million - $4.27 Million
-29,924 Reduced 2.81%
1,036,788 $142 Million
Q1 2020

May 13, 2020

SELL
$92.66 - $144.94 $15.4 Million - $24 Million
-165,779 Reduced 13.45%
1,066,712 $126 Million
Q4 2019

Feb 14, 2020

BUY
$116.25 - $133.25 $31.7 Million - $36.3 Million
272,381 Added 28.37%
1,232,491 $163 Million
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $9.34 Million - $10.7 Million
82,928 Added 9.45%
960,110 $120 Million
Q2 2019

Aug 14, 2019

BUY
$97.98 - $114.28 $128,843 - $150,278
1,315 Added 0.15%
877,182 $99.6 Million
Q1 2019

May 10, 2019

SELL
$81.56 - $100.67 $190,361 - $234,963
-2,334 Reduced 0.27%
875,867 $88.2 Million
Q4 2018

Feb 13, 2019

BUY
$79.28 - $95.27 $2.45 Million - $2.94 Million
30,883 Added 3.64%
878,201 $75.1 Million
Q3 2018

Nov 13, 2018

BUY
$83.5 - $93.23 $29.9 Million - $33.4 Million
358,489 Added 73.34%
847,318 $77.6 Million
Q2 2018

Aug 10, 2018

SELL
$79.9 - $89.2 $22.3 Million - $24.9 Million
-278,931 Reduced 36.33%
488,829 $41.6 Million
Q1 2018

May 09, 2018

SELL
$71.51 - $84.69 $34.5 Million - $40.9 Million
-483,069 Reduced 38.62%
767,760 $64.1 Million
Q4 2017

Feb 14, 2018

BUY
$63.24 - $72.8 $572,195 - $658,694
9,048 Added 0.73%
1,250,829 $0
Q3 2017

Nov 13, 2017

BUY
$59.73 - $65.4 $74.2 Million - $81.2 Million
1,241,781
1,241,781 $79.2 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.